Huamao Mark Lin
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 5%
- Molecular Biology
- Cancer Research top 10%
- Immunology
- Co-authors
- Barbara E. BiererYu YinJianchang LinDanny NguyenSylvie VincentMinal MehtaShu JinMohammad Jahanzeb
- Topics
- Lung Cancer Treatments and Mutations (47 papers)Lung Cancer Research Studies (22 papers)Lung Cancer Diagnosis and Treatment (13 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Huamao Mark Lin
72 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Pulmonary and Respiratory Medicine 618
- Oncology 582
- Molecular Biology 317
- Cancer Research 166
- Immunology 128
Countries citing papers authored by Huamao Mark Lin
This map shows the geographic impact of Huamao Mark Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huamao Mark Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huamao Mark Lin more than expected).
Fields of papers citing papers by Huamao Mark Lin
This network shows the impact of papers produced by Huamao Mark Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huamao Mark Lin. The network helps show where Huamao Mark Lin may publish in the future.
Co-authorship network of co-authors of Huamao Mark Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Huamao Mark Lin. A scholar is included among the top collaborators of Huamao Mark Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huamao Mark Lin. Huamao Mark Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 11 | |
| 3 | 28 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 25 | |
| 8 | 27 | |
| 9 | 0 | |
| 10 | 17 | |
| 11 | 8 | |
| 12 | 12 | |
| 13 | 47 | |
| 14 | 9 | |
| 15 | 16 | |
| 16 | 1 | |
| 17 | 7 | |
| 18 | 48 | |
| 19 | 47 | |
| 20 | 10 |
About Huamao Mark Lin
Huamao Mark Lin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 73 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (47 papers), Lung Cancer Research Studies (22 papers) and Lung Cancer Diagnosis and Treatment (13 papers). The work is most often cited by research in Oncology (582 citations), Pulmonary and Respiratory Medicine (618 citations) and Cancer Research (166 citations). Huamao Mark Lin has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Barbara E. Bierer, Yu Yin, Jianchang Lin, Danny Nguyen, Sylvie Vincent, Minal Mehta, Shu Jin, Mohammad Jahanzeb, Sai‐Hong Ignatius Ou and Xiaoyun Pan. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.